YCBD cbdMD, Inc.
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1644903 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY10.0%
TTM net income YoY-90.8%
TTM EPS YoY—
Revenue 3-yr CAGR-7.3%
Net income 3-yr CAGR—
Margins
Gross margin57.7%
Operating margin-13.9%
Net margin-13.8%
FCF margin-11.5%
EBITDA margin-12.8%
Returns
ROE-40.3%
ROA-25.1%
ROIC (approx.)-41.2%
Asset turnover1.82x
Leverage & solvency
Liabilities / assets37.5%
Debt / equity0.00x
Current ratio2.50x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.77x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-06-30 | 2026Q22026-03-31 | 2025Q12025-12-31 | 2025Q4*2025-09-30 | 2025Q32025-06-30 | 2025Q22025-03-31 | 2025Q12024-12-31 | 2024Q4*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $5.55M | $5.64M | $5.02M | $4.72M | $4.61M | $4.75M | $5.11M | $4.56M |
| Cost of revenue | $2.52M | $2.38M | $2.02M | $1.94M | $1.78M | $1.79M | $1.71M | $2.10M |
| Gross profit | $3.04M | $3.26M | $3.00M | $2.78M | $2.83M | $2.96M | $3.40M | $2.45M |
| Operating income | -$1.13M | -$800,784 | -$286,288 | -$685,816 | -$904,686 | -$485,816 | -$86,272 | -$316,555 |
| Pretax income | -$1.13M | -$797,978 | -$283,131 | -$679,968 | -$895,272 | -$480,757 | $15,095 | -$152,799 |
| Net income | -$1.13M | -$797,978 | -$283,131 | -$679,968 | -$895,272 | -$480,757 | $15,095 | -$152,798 |
| EBITDA | -$1.09M | -$756,078 | -$232,128 | -$615,028 | -$815,781 | -$391,187 | $20,468 | -$207,756 |
| EPS (basic) | -0.11 | -0.08 | -0.04 | — | -0.21 | -1.90 | -1.73 | — |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Banking | ||||||||
| Net interest income | $3,275 | $2,806 | $3,157 | $5,848 | $9,414 | $7,642 | $11,404 | $2,051 |
| Balance sheet | ||||||||
| Cash & equivalents | $2.12M | $2.64M | $3.39M | $2.26M | $1.06M | $1.77M | $1.97M | $2.45M |
| Receivables | $926,846 | $820,935 | $744,662 | $786,449 | $746,165 | $694,515 | $631,033 | $621,678 |
| Inventory | $3.47M | $3.65M | $3.14M | $2.95M | $3.18M | $2.88M | $2.47M | $2.52M |
| Current assets | $7.70M | $8.38M | $8.17M | $6.55M | $5.60M | $6.19M | $6.36M | $6.39M |
| PP&E, net | $334,840 | $361,119 | $388,018 | $277,377 | $345,361 | $432,792 | $511,915 | $454,268 |
| Goodwill | $190,000 | $190,000 | — | $0 | — | — | — | — |
| Intangibles | $1.98M | $2.19M | $2.12M | $2.12M | $2.32M | $2.51M | $2.70M | $2.89M |
| Total assets | $13.15M | $12.25M | $11.78M | $10.42M | $9.90M | $10.94M | $11.54M | $10.58M |
| Current liabilities | $3.08M | $2.97M | $2.77M | $3.19M | $3.58M | $9.87M | $9.17M | $8.62M |
| Total liabilities | $4.93M | $2.97M | $2.77M | $3.19M | $3.78M | $10.27M | $9.76M | $8.62M |
| Shareholders' equity | $8.21M | $9.28M | $9.01M | $7.23M | $6.11M | $665,798 | $1.78M | $1.96M |
| Shares outstanding | 11.12M | 10.50M | 10.07M | 8.92M | 8.91M | 783,355 | 5.54M | 492,383 |
| Cash flow statement | ||||||||
| Operating cash flow | -$442,158 | -$722,500 | -$812,464 | -$240,749 | -$704,200 | -$189,477 | -$317,949 | $167,377 |
| Capital expenditure | $18,065 | $5,748 | $164,802 | $2,804 | $1,475 | $15,506 | $164,387 | $10,000 |
| Free cash flow | -$460,223 | -$728,248 | -$977,266 | -$243,553 | -$705,675 | -$204,983 | -$482,336 | $157,377 |
| Investing cash flow | -$18,065 | $50,679 | -$164,802 | -$2,804 | -$1,475 | -$15,506 | -$164,387 | -$110,000 |
| Financing cash flow | -$59,681 | -$77,869 | $2.10M | $1.45M | $0 | $0 | $0 | $1 |
| Depreciation & amortization | $44,344 | $44,706 | $54,160 | $70,788 | $88,905 | $94,629 | $106,740 | $108,799 |
| Dividends paid | — | — | — | — | — | $1.00M | $1.01M | — |
Free plan shows the latest 8 periods; Pro shows all 39 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.